Yaqian Cui

Wenzhou, 325899, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Compound J27 alleviates obesity-induced cardiomyopathy by targeting JNK2.

Compound J27 alleviates obesity-induced cardiomyopathy by targeting JNK2.

Journal: International immunopharmacology

Published: February 05, 2026

Pedunculoside ameliorates liver fibrosis by targeting c-Jun to inhibit hepatic stellate cell activation.

Pedunculoside ameliorates liver fibrosis by targeting c-Jun to inhibit hepatic stellate cell activation.

Journal: International immunopharmacology

Published: December 22, 2025

Eupalinolide B ameliorates liver fibrosis by targeting PKCα to suppress the AKT/mTOR axis in hepatic stellate cells.

Eupalinolide B ameliorates liver fibrosis by targeting PKCα to suppress the AKT/mTOR axis in hepatic stellate cells.

Journal: Journal of ethnopharmacology

Published: December 05, 2025

Hepatocyte BDNF Acts as a Novel Immune Checkpoint to Restrain TLR4-Mediated Acute Hepatitis.

Hepatocyte BDNF Acts as a Novel Immune Checkpoint to Restrain TLR4-Mediated Acute Hepatitis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 23, 2025

1-O-acetylbritannilactone alleviates high-fat diet-induced fatty liver by covalently targeting NLRP3.

1-O-acetylbritannilactone alleviates high-fat diet-induced fatty liver by covalently targeting NLRP3.

Journal: International immunopharmacology

Published: October 20, 2025

Lumican-TLR4 interaction accelerates hepatic fibrosis by activating hepatic stellate cells.

Lumican-TLR4 interaction accelerates hepatic fibrosis by activating hepatic stellate cells.

Journal: Hepatology communications

Published: October 09, 2025

Isolinderalactone attenuates atherosclerosis through inhibiting NF-κB-mediated inflammation in macrophages.

Isolinderalactone attenuates atherosclerosis through inhibiting NF-κB-mediated inflammation in macrophages.

Journal: International immunopharmacology

Published: July 20, 2025

Brain-derived neurotrophic factor and the derived dodecapeptide function as Toll-like receptor 4 antagonists in acute lung injury.

Brain-derived neurotrophic factor and the derived dodecapeptide function as Toll-like receptor 4 antagonists in acute lung injury.

Journal: Nature communications

Published: June 18, 2025

USP13 promotes hepatic stellate cells activation and aggravates liver fibrosis through deubiquitinating SMAD3.

USP13 promotes hepatic stellate cells activation and aggravates liver fibrosis through deubiquitinating SMAD3.

Journal: Hepatology international

Published: April 05, 2025

Discovery of Novel MyD88 Inhibitor A5S to Alleviate Acute Lung Injury with Favorable Drug-like Properties.

Discovery of Novel MyD88 Inhibitor A5S to Alleviate Acute Lung Injury with Favorable Drug-like Properties.

Journal: Journal of medicinal chemistry

Published: December 07, 2024

β-elemene ameliorates metabolic dysfunction-associated steatohepatitis by targeting PPARα in experimental diet-induced models.

β-elemene ameliorates metabolic dysfunction-associated steatohepatitis by targeting PPARα in experimental diet-induced models.

Journal: British journal of pharmacology

Published: November 28, 2024

The natural product-derived JM-9 alleviates high-fat diet-induced fatty liver in mice by targeting MD2.

The natural product-derived JM-9 alleviates high-fat diet-induced fatty liver in mice by targeting MD2.

Journal: International immunopharmacology

Published: October 30, 2024

Showing 1-12 of 17

Last Updated: 09/26/2026